ELEANOR SIGALAS: Open Payments
NPI 1780034868 · GRETNA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$240 in 6 payments from 4 companies in 2025. Trend: 2023 $196 · 2024 $892 · 2025 $240
Food & beverage: $240
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $171 |
| Lundbeck LLC | 1 | $25 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| ABBVIE INC. | 1 | $21 |
Products named: BREZTRI, FARXIGA, REXULTI, TRELEGY ELLIPTA, VRAYLAR.
Industry payments across LA — which companies pay providers there.
